KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Thoracic Journal / 2018 / Cilt: 19 - Sayı: 4

Unexpected Pregnancy during Treatment of Multidrug-resistant Tuberculosis

Rafael Laniado LABORIN
Kenia Carrera LOPEZ
Ana Hernandez PEREZ
Sayfa
226–227
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We present a case of pregnancy in a teenager while she wasunder treatment for MDR-TB and continued with full treatment and nevertheless delivered a healthy child.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Several drugs used in the treatment of multidrug-resistant tuberculosis (MDR-TB) have been reported as teratogenic.
📊
Temel Bulgular & Veri:Treatment of suchcases during gestation is disputable.
💡
Sonuç & Katkı:We present a case of pregnancy in a teenager while she wasunder treatment for MDR-TB and continued with full treatment and nevertheless delivered a healthy child.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Several drugs used in the treatment of multidrug-resistant tuberculosis (MDR-TB) have been reported as teratogenic. Treatment of suchcases during gestation is disputable. Some experts favor the termination of pregnancy, whereas others suggest reducing the dose of teratogenicdrugs or even suspending the regimen during pregnancy. There have been no clinical trials on the subject, but case reports and caseseries show excellent outcomes for children exposed during pregnancy to second-line agents, indicating that aggressive managementof gestational MDR-TB may benefit not only the mother but also the fetus. We present a case of pregnancy in a teenager while she wasunder treatment for MDR-TB and continued with full treatment and nevertheless delivered a healthy child.

🔖

Bu Makaleye Atıf Yap

LABORIN, R. L., LOPEZ, K. C., PEREZ, A. H. (2018). Unexpected Pregnancy during Treatment of Multidrug-resistant Tuberculosis. Turkish Thoracic Journal, Cilt: 19 - Sayı: 4, 226–227. https://ajindex.com/articles/418034

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Curry International Tuberculosis Center and California Department of Public Health. Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, 3rd Edition, Editor: Curry International Tuberculosis Center. 2016; 187-8
  2. Craig GM, Booth H, Story A, et al. The impact of social factors on tuberculosis management. J Adv Nurs 2007; 58: 418-24. [CrossRef] 3. Sagwa EL, Ruswa N, Mavhunga F, et al. Comparing amikacin and kanamycin induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort. BMC Pharmacol Toxicol 2015; 16: 36. [CrossRef] 4. Loto OM, Awowole I. Tuberculosis in Pregnancy: A Review. J Pregnancy 2012; 2012: 379271
  3. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-62. [CrossRef] 6. Palacios E, Dallman R, Munoz M, et al. Drug-Resistant Tuberculosis and Pregnancy: Treatment Outcomes of 38 Cases in Lima, Peru. Clin Infect Dis 2009; 48: 1413-9. [CrossRef] 7. Shin S, Guerra D, Rich M, et al. Treatment of Multidrug-Resistant Tuberculosis during Pregnancy: a Report of 7 Cases. Clin Infect Dis 2003; 36: 996-1003. [CrossRef] 8. Rohilla M, Joshi B, Jain V, et al. Multidrug-Resistant Tuberculosis during Pregnancy: Two Case Reports and Review of the Literature. Case Rep Obstet Gynecol 2016; 2016: 1536281. [CrossRef] 9. Drobac PC, del Castillo H, Sweetland A, et al. Treatment of multidrug-resistanttuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis 2005; 40: 1689-92. [CrossRef] 10. Arbex MA, Varella M de C, Siqueira HR, et al. Antituberculosis drugs: Drug interactions, adverse effects, and use in special situations. Part 2: Second-line drugs. J Bras Pneumol 2010; 36: 641-56. [CrossRef] 11. T Joint. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1988; 53: 536-48.